EMEA-001439-PIP01-13-M03
Key facts
Invented name |
Exviera
|
Active substance |
Dasabuvir (sodium monohydrate)
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0289/2020
|
PIP number |
EMEA-001439-PIP01-13-M03
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of chronic hepatitis C
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
AbbVie Ltd
AbbVie Ltd |
Decision type |
PM: decision on the application for modification of an agreed PIP
|